![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, March 12, 2014 10:34:43 AM
http://stemcellceo.com/wp/bioheart/thank-you/
Our upcoming 10K (which will be filed on-time prior to March 31st) will outline the results of our recent commercial programs, for example:
Our physician training programs in the field of cellular medicine continues at a fast pace
Partnering with Anosis Biomedical Limited to distribute Bioheart therapies to patients in the Middle East and surrounding areas. Bioheart announced that its first successful adipose derived stem cell (ADSC) implantation was performed in Azerbaijan at Baku Central Military Hospital. Azerbaijan is the largest country in the region located at the crossroads of Western Asia and Eastern Europe.
Bioheart announced exclusive license in veterinary medicine for patents for cancer-related immunotherapy products from inventor Allan Wu, M.D.
Bioheart has extended licenses of electrical stimulation patents with Airspeed for MyoStim product line. Bioheart has successfully been treating patients for a range of conditions for almost 15 years with our autologous cellular products.
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM